Literature DB >> 11791185

Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor.

Liu Yang1, Li Xia, Daniel Y Wu, Hengbin Wang, Howard A Chansky, William H Schubach, Dennis D Hickstein, Yi Zhang.   

Abstract

The ets-related gene erg encodes a transcription factor that is implicated in the control of cell growth and differentiation. To identify interacting partners of ERG, we screened a yeast two-hybrid cDNA library constructed from mouse hematopoietic cells using the N-terminal region of ERG as a bait. We isolated a 4.6 kb full-length mouse cDNA encoding a 1307-amino acid protein migrating as a 180 kD band, which was termed ESET (ERG-associated protein with SET domain). ESET is 92% identical to the human protein SETDB1 (SET domain, bifurcated 1). The interaction between ESET and ERG was supported by in vitro pull-down using glutathione S-transferase (GST) fusion protein, by transfection and co-immunoprecipitation experiments, and by association of endogenous SETDB1 with ERG. Since ESET possesses evolutionarily conserved SET, preSET, and postSET domains implicated in histone methylation, we tested the ability of ESET to methylate core histones. The results of these studies demonstrated that ESET is a histone H3-specific methyltransferase, and that mutations within ESET abolished its methyltransferase activity. Together, these findings raise the possibility that transcription factor ERG may participate in transcriptional regulation through ESET-mediated histone methylation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791185     DOI: 10.1038/sj.onc.1204998

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  102 in total

1.  Ten members of the Arabidopsis gene family encoding methyl-CpG-binding domain proteins are transcriptionally active and at least one, AtMBD11, is crucial for normal development.

Authors:  Anita Berg; Trine J Meza; Mirela Mahić; Tage Thorstensen; Kjetil Kristiansen; Reidunn B Aalen
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

Review 2.  An increasingly complex code.

Authors:  Hugh T Spotswood; Bryan M Turner
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

3.  Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis.

Authors:  William R Coward; Keira Watts; Carol A Feghali-Bostwick; Gisli Jenkins; Linhua Pang
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

4.  Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.

Authors:  Yan Jiang; Anouch Matevossian; Yin Guo; Schahram Akbarian
Journal:  Neuropharmacology       Date:  2010-09-30       Impact factor: 5.250

5.  PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure.

Authors:  Tomas Stopka; Derek F Amanatullah; Michael Papetti; Arthur I Skoultchi
Journal:  EMBO J       Date:  2005-10-13       Impact factor: 11.598

Review 6.  The contradictory definitions of heterochromatin: transcription and silencing.

Authors:  Kathryn L Huisinga; Brent Brower-Toland; Sarah C R Elgin
Journal:  Chromosoma       Date:  2006-02-28       Impact factor: 4.316

7.  Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.

Authors:  Haidong Gao; Zhigang Yu; Dongsong Bi; Liyu Jiang; Yazhou Cui; Jingzhong Sun; Rong Ma
Journal:  Mol Cell Biochem       Date:  2007-06-19       Impact factor: 3.396

Review 8.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 9.  Epigenetic regulation in human brain-focus on histone lysine methylation.

Authors:  Schahram Akbarian; Hsien-Sung Huang
Journal:  Biol Psychiatry       Date:  2008-09-24       Impact factor: 13.382

10.  Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease.

Authors:  Junghee Lee; Yu Jin Hwang; Jong-Yeon Shin; Won-Chul Lee; Jinhong Wie; Ki Yoon Kim; Min Young Lee; Daehee Hwang; Rajiv R Ratan; Ae Nim Pae; Neil W Kowall; Insuk So; Jong-Il Kim; Hoon Ryu
Journal:  Acta Neuropathol       Date:  2013-03-02       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.